Drug Database · Clinicians

Erlotinib as

Brands (1) RiltaredShow all

This entry appears to be Erlotinib registered under a variant spelling.

See the main Erlotinib monograph (kidney dosing, prescribing information, all brands) →

US brand (reference label): Erlotinib; not a Philippine-registered brand.

Antineoplastic agent (protein kinase inhibitor) PH FDA category

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID daaa1329-3a3f-439c-b13d-b301daa234d4, version date November 28, 2024 (Erlotinib · Zydus Lifesciences Limited). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 150 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Erlotinib as as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Erlotinib as
Package insert
RiltaredErlotinib (as hydrochloride
150 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's)
Rx
Dr. Reddy's Laboratories Ltd. (Formulation FTO-7)India
Dr. Reddy's Laboratories Philippines Inc.
DR-XY48549
Dec 29, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Erlotinib · Zydus Lifesciences Limited [US FDA-approved label, version 3, November 28, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=daaa1329-3a3f-439c-b13d-b301daa234d4
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .